{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:14:47Z","timestamp":1788520487040,"version":"build-2803163510"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0218670","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T17:31:05Z","timestamp":1561138265000},"page":"e0218670","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Phosphodiesterase 4D, miR-203 and selected cytokines in the peripheral blood are associated with canine atopic dermatitis"],"prefix":"10.1371","volume":"14","author":[{"given":"Jeffrey","family":"Koury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fari","family":"Izadyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Drechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6769-9069","authenticated-orcid":true,"given":"Jijun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"issue":"3\u20134","key":"ref1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-2427(01)00296-3","article-title":"The ACVD task force on canine atopic dermatitis (I): Incidence and prevalence","volume":"81","author":"A Hillier","year":"2001","journal-title":"Veterinary Immunology and Immunopathology"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/vde.12197","article-title":"Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction","volume":"26","author":"D Santoro","year":"2015","journal-title":"Vet Dermatol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"S Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"ref4","article-title":"Atopic Dermatitis in Animals and People: An Update and Comparative Review","volume":"4","author":"R Marsella","year":"2017","journal-title":"Vet Sci"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-2222.2002.01356.x","article-title":"Expression of Th1, Th2 and immunosuppressive cytokine gene transcripts in canine atopic dermatitis","volume":"32","author":"TJ Nuttall","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0625.1999.tb00372.x","article-title":"Toward a canine model of atopic dermatitis: amplification of cytokine-gene transcripts in the skin of atopic dogs","volume":"8","author":"T Olivry","year":"1999","journal-title":"Experimental Dermatology"},{"issue":"1\u20132","key":"ref7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vetimm.2013.10.017","article-title":"Allergen-induced production of IL-31 by canine Th2 cells and identification of immune, skin, and neuronal target cells","volume":"157","author":"EE McCandless","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jid.2016.05.117","article-title":"Early Activation of Th2\/Th22 Inflammatory and Pruritogenic Pathways in Acute Canine Atopic Dermatitis Skin Lesions","volume":"136","author":"T Olivry","year":"2016","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/vde.12140","article-title":"CD4+ and CD8+ skin-associated T lymphocytes in canine atopic dermatitis produce interleukin-13, interleukin-22 and interferon-gamma and contain a CD25+ FoxP3+ subset","volume":"25","author":"A Jassies-van der Lee","year":"2014","journal-title":"Vet Dermatol"},{"issue":"3\u20134","key":"ref10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0165-2427(01)00312-9","article-title":"The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis","volume":"81","author":"DJ DeBoer","year":"2001","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12917-016-0805-6","article-title":"Lymphocytic, cytokine and transcriptomic profiles in peripheral blood of dogs with atopic dermatitis","volume":"12","author":"A Majewska","year":"2016","journal-title":"BMC Vet Res"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2478\/bvip-2013-0063","article-title":"Expression of CD3, CD4, CD8, CD21, and MHC II lymphocyte antigens and serum IL-10 concentration in dogs with atopic dermatitis complicated by purulent dermatitis","volume":"57","author":"I. Taszkun","year":"2013","journal-title":"Bulletin of the Veterinary Institute in Pulawy"},{"issue":"Suppl 1","key":"ref13","first-page":"58","article-title":"Changes in the CD4\/CD8-positive T lymphocyte ratio in the blood of atopic and non-atopic dogs","volume":"23","author":"N TM Tarpataki","year":"2012","journal-title":"Vet Dermatol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-3164.2012.01098.x","article-title":"Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis","volume":"24","author":"AJ Gonzales","year":"2013","journal-title":"Vet Dermatol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/vde.12277","article-title":"Lymphocyte subpopulations and Treg cells in dogs with atopic dermatitis receiving ciclosporin therapy: a prospective study","volume":"27","author":"M Beccati","year":"2016","journal-title":"Vet Dermatol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-013-0023-0","article-title":"Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases","volume":"3","author":"M Wittmann","year":"2013","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-3164.2007.00576.x","article-title":"Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes","volume":"18","author":"W Baumer","year":"2007","journal-title":"Vet Dermatol"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes: molecular targets for novel antiasthma agents","volume":"157","author":"TJ Torphy","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref19","first-page":"1236","article-title":"Curr Opin Investig Drugs","volume":"10","author":"R Nazarian","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.bmcl.2009.03.007","article-title":"Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis","volume":"19","author":"T Akama","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archdermatol.2012.812","article-title":"A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults","volume":"148","author":"A Samrao","year":"2012","journal-title":"Arch Dermatol"},{"issue":"3","key":"ref22","first-page":"341","article-title":"A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis","volume":"11","author":"EM Volf","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/1346-8138.12534","article-title":"Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial","volume":"41","author":"M Furue","year":"2014","journal-title":"J Dermatol"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1346-8138.13231","article-title":"Effect of topical phosphodiesterase 4 inhibitor E6005 on Japanese children with atopic dermatitis: Results from a randomized, vehicle-controlled exploratory trial","volume":"43","author":"O Nemoto","year":"2016","journal-title":"J Dermatol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","article-title":"Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults","volume":"75","author":"AS Paller","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/vr.145.7.191","article-title":"Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis","volume":"145","author":"L Ferrer","year":"1999","journal-title":"Vet Rec"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.trsl.2011.01.007","article-title":"MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases","volume":"157","author":"R Dai","year":"2011","journal-title":"Transl Res"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"e115448","DOI":"10.1371\/journal.pone.0115448","article-title":"Profiling of Serum and Urinary MicroRNAs in Children with Atopic Dermatitis","volume":"9","author":"Y Lv","year":"2014","journal-title":"PLOS ONE"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jid.2016.03.015","article-title":"Canine and Human Atopic Dermatitis: Two Faces of the Same Host-Microbe Interaction","volume":"136","author":"D Santoro","year":"2016","journal-title":"J Invest Dermatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12917-015-0515-5","article-title":"Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification","volume":"11","author":"P Hensel","year":"2015","journal-title":"BMC Vet Res"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-015-0515-5","article-title":"Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification","volume":"11","author":"P Hensel","year":"2015","journal-title":"Bmc Veterinary Research"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.5021\/ad.2011.23.4.468","article-title":"IL-31 Serum Protein and Tissue rnRNA Levels in Patients with Atopic Dermatitis","volume":"23","author":"S Kim","year":"2011","journal-title":"Annals of Dermatology"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4161\/self.2.2.16939","article-title":"Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals","volume":"2","author":"ES Fedenko","year":"2011","journal-title":"Self Nonself"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/vr.152.6.159","article-title":"Studies of serum total immunoglobulin E concentrations in atopic and non-atopic dogs","volume":"152","author":"MA Fraser","year":"2003","journal-title":"Vet Rec"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-2427(94)05298-7","article-title":"Concentrations of total serum IgE, IgA, and IgG in atopic and parasitized dogs","volume":"44","author":"PB Hill","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"DH Maurice","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"ref37","first-page":"1389","article-title":"Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis","volume":"77","author":"J Ahluwalia","year":"2017","journal-title":"Progress and Outlook. Drugs"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2016.00222","article-title":"Molecular Mechanisms for cAMP-Mediated Immunoregulation in T cells\u2014Role of Anchored Protein Kinase A Signaling Units","volume":"7","author":"VL Wehbi","year":"2016","journal-title":"Front Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fimmu.2018.00050","article-title":"Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation","volume":"9","author":"T Veremeyko","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nbt.1598","article-title":"Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety","volume":"28","author":"AB Burgin","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"22","key":"ref41","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","article-title":"Phosphodiesterase-4 as a therapeutic target","volume":"10","author":"MD Houslay","year":"2005","journal-title":"Drug Discovery Today"},{"issue":"21","key":"ref42","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1021\/jm900977c","article-title":"New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoforms","volume":"52","author":"O Bruno","year":"2009","journal-title":"J Med Chem"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.celrep.2015.03.001","article-title":"An in vivo chemical genetic screen identifies phosphodiesterase 4 as a pharmacological target for hedgehog signaling inhibition","volume":"11","author":"CH Williams","year":"2015","journal-title":"Cell Rep"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpba.2018.01.009","article-title":"A simple and sensitive HPLC-MS\/MS method for quantification of eggmanone in rat plasma and its application to pharmacokinetics","volume":"153","author":"C Xie","year":"2018","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?","volume":"2","author":"E Sonkoly","year":"2007","journal-title":"PLoS One"},{"issue":"7184","key":"ref46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature06642","article-title":"A skin microRNA promotes differentiation by repressing 'stemness'","volume":"452","author":"R Yi","year":"2008","journal-title":"Nature"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1620\/tjem.154.157","article-title":"Comparative-Analysis of Lymphocyte Phenotypes between Carriers of Human Immunodeficiency Virus (Hiv) and Adult Patients with Primary Immunodeficiency Using 2-Color Immunofluorescence Flow-Cytometry","volume":"154","author":"T Ohno","year":"1988","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"ref48","first-page":"189096","article-title":"CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis","volume":"2012","author":"MP Pender","year":"2012","journal-title":"Autoimmune Dis"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cell.2015.08.025","article-title":"Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses","volume":"162","author":"MF Farez","year":"2015","journal-title":"Cell"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1399-3038.2011.01241.x","article-title":"IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis","volume":"23","author":"U Raap","year":"2012","journal-title":"Pediatric Allergy and Immunology"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","DOI":"10.1111\/vde.12500","article-title":"Investigation of the correlation of serum IL-31 with severity of dermatitis in an experimental model of canine atopic dermatitis using beagle dogs","volume":"29","author":"R Marsella","year":"2018","journal-title":"Veterinary Dermatology"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/all.12049","article-title":"Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine","volume":"67","author":"T. Bieber","year":"2012","journal-title":"Allergy"},{"issue":"2","key":"ref53","first-page":"338","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"LF Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1\u20132","key":"ref54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vetimm.2011.05.025","article-title":"Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness","volume":"143","author":"YM Schlotter","year":"2011","journal-title":"Veterinary Immunology and Immunopathology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0218670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T03:06:41Z","timestamp":1721444801000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0218670"}},"subtitle":[],"editor":[{"given":"Michel","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0218670","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]}}}